The NogoB/NgBR signaling axis is suggested to modulate the EGF/Ras/Raf/ERK and PI3K/Akt signaling pathways [60] and increases the expression of an anti-apoptotic protein called survivin, both of which are shown to be associated with the development and survival of breast tumor cells [51]. Here, RTN4 is linked to breast neoplasm.